France· FR:67401121
IMUKIN 2 x 10<sup>6</sup> UI (0,1 mg), solution injectable
A interferon gamma-1b product containing interféron gamma-1b, registered in France by CLINIGEN HEALTHCARE (PAYS BAS). The same ATC class is registered in 3 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Interferon gamma-1b is registered in 3 of 19 countries.
Countries holding a registration under ATC L03AB18 (interferon gamma-1b), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 3 of them publish a price we can compare per daily dose
Interferon gamma-1b · ATC L03AB18
3 / 19 countries
- Franceprice
- Spainprice
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- INTERFÉRON GAMMA-1B
- Manufacturer
- CLINIGEN HEALTHCARE (PAYS BAS)
- Country
- France (FR)
- ATC code
- L03AB18
- ATC class
- Interferon gamma-1b
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009557767891 flacon(s) en verre de 0,5 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
80 interactions on record for interferon gamma-1b.
Graded by severity as the source publishes them — 27 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Interferon gamma-1b · interactions on record
80 records
- 27 severe
- 53 moderate
Most severe, free to view
- CladribineL01BB04severe
- BexaroteneL01XF03severe
- BexarotenL01XX25severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Interferon gamma-1b in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayImukinClinigen
- United StatesACTIMMUNEHorizon Therapeutics USA, Inc.
- SpainIMUKIN 100 microgramos SOLUCION INYECTABLEClinigen Healthcare B.V.
- BelgiumImmukine 0,10 mgHorizon Pharma Ireland
- NetherlandsIMMUKINE, oplossing voor injectie 2 x 10.6 IE (0,1 mg)Clinigen Healthcare B.V.
- FinlandImukinBoehringer Ingelheim International GmbH
- GermanyImukinClinigen Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Germany · Imukin
- Spain · Imukin
- United Kingdom (Northern Ireland) · Immukin
- Italy · Imukin
- Netherlands · Immukine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ca924be3-9897-4bf9-9a32-07008cbfb1a1 GET /v1/drugs/ca924be3-9897-4bf9-9a32-07008cbfb1a1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67401121",
"date_amm": "1992-09-30",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "INTERFÉRON GAMMA-1B",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about interferon gamma-1b.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.